-+ 0.00%
-+ 0.00%
-+ 0.00%

Innovent Biologics Doses First Patient in Phase 3 Trial of Novel HER2 ADC for Advanced Breast Cancer

路透·02/13/2026 00:00:20

登錄查看新聞詳情